Details are only in Thai Page.

Atrial fibrillation is an irregular heart beat which can cause blood clot in the heart and embolic stroke. Prevention of stroke can be managed by anticoagulation (Blood thinner). However, some patients are contraindicated to the blood thinner. Left atrium appendage (LAA) occluder device is a new technology developed to occupy the space in the heart (LAA) where the blood clot forms as an alternative treatment for blood thinner. The device placement can be performed by catheter technique via the access of the artery beneath the groin area without a need for open heart surgery. The length of hospital stay is 1-2 days.

Cardiac Center at King Chulalongkorn Memorial Hospital is the first in Thailand successfully performed LAA occlude device placement in two patients with atrial fibrillation. More details are in Thai.

KCMH (King Chulalongkorn Memorial Hospital) Cardiac Center has recently introduced a new medical technology to treat resistant hypertension. The link of heart and kidney strongly plays an important role of neurohormonal signal to control blood pressure. Ablation of renal nerve results in a significant reduction in blood pressure. Led by Drs. Jakarpun Chaipromprasit and Suphot Srimahachota and colleagues, KCMH successfully performed renal nerve denervation in resistant hypertensive patients. More details are in Thai.

Biodegradable Stent

Recently, biodegradable stent is a promising tehnology to permanently place, and may  be used to solve the  problem of in-stent restenosis.  More details are here.

The KCMH cardiac center proudly launched a new device for percutaneous closure of ventricular septal defect (VSD). The device was created by Pornthep Lertsapcharoen, MD, and made of Nitinol. Of 16 patients with VSDs, 12 patients  underwent successful closure without a need for open heart surgery.

Read more